Labcorp Quarterly Balance Sheet
NYSE: LHHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Labcorp financial position
As of Jun 30, 2026, Labcorp reported total assets of $18.53 billion, up 2.6% from a year earlier against total liabilities of $9.91 billion. Shareholders' equity stood at $8.61 billion, or 46.4% of assets. The company held $141.8 million in cash and equivalents against $5.86 billion of debt, a net debt position of $5.72 billion.
The current ratio (current assets divided by current liabilities) was 1.80, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.68.
Summary generated from market data by MetaCap's automated system. Methodology
Labcorp balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 141.80M | 981.10M | 532.30M | 598.10M | 647.30M | 369.40M | 1.52B | 1.52B | 265.10M | 99.30M | 536.80M | 727.90M |
| Receivables | 2.34B | 2.29B | 2.10B | 2.11B | 2.12B | 2.12B | 1.94B | 2.06B | 2.09B | 2.08B | 1.91B | 1.96B |
| Inventory | 562.20M | 497.70M | 534.70M | 521.50M | 508.10M | 488.30M | 493.20M | 483.10M | 441.80M | 475.00M | 474.60M | 461.10M |
| Total Current Assets | 3.81B | 4.56B | 4.02B | 4.08B | 4.09B | 3.79B | 4.81B | 4.91B | 3.57B | 3.46B | 3.77B | 3.95B |
| Property, Plant & Equipment | 3.10B | 3.07B | 3.08B | 3.11B | 3.13B | 3.09B | 3.05B | 3.05B | 2.93B | 2.90B | 2.91B | 2.82B |
| Goodwill | 7.03B | 6.96B | 6.79B | 6.68B | 6.55B | 6.42B | 6.37B | 6.48B | 6.22B | 6.22B | 6.14B | 6.33B |
| Intangible Assets | 3.68B | 3.64B | 3.60B | 3.57B | 3.49B | 3.49B | 3.49B | 3.54B | 3.33B | 3.39B | 3.34B | 3.28B |
| Total Assets | 18.53B | 19.09B | 18.39B | 18.26B | 18.06B | 17.60B | 18.38B | 18.61B | 16.71B | 16.53B | 16.73B | 16.89B |
| Accounts Payable | 688.50M | 695.70M | 840.80M | 668.50M | 793.00M | 717.90M | 875.80M | 660.90M | 760.60M | 695.50M | 827.50M | 690.60M |
| Short-Term Debt | 900.00K | 500.40M | 500.10M | — | — | — | 1.00B | — | — | — | 999.80M | — |
| Total Current Liabilities | 2.12B | 2.64B | 2.82B | 2.63B | 2.72B | 2.06B | 3.33B | 3.41B | 4.06B | 3.94B | 3.23B | 2.90B |
| Long-Term Debt | 5.86B | 5.83B | 5.08B | 5.08B | 5.08B | 5.57B | 5.33B | 5.35B | 3.05B | 3.05B | 4.05B | 4.43B |
| Total Liabilities | 9.91B | 10.34B | 9.76B | 9.55B | 9.57B | 9.28B | 10.31B | 10.43B | 8.69B | 8.56B | 8.83B | 8.99B |
| Shareholders' Equity | 8.61B | 8.73B | 8.62B | 8.70B | 8.47B | 8.31B | 8.05B | 8.17B | 8.01B | 7.96B | 7.88B | 7.87B |
| Retained Earnings | 8.70B | 8.78B | 8.64B | 8.70B | 8.50B | 8.46B | 8.30B | 8.28B | 8.18B | 8.06B | 7.89B | 8.07B |
| Total Debt | 5.86B | 6.33B | 5.58B | 5.08B | 5.08B | 5.57B | 6.33B | 5.35B | 3.05B | 3.05B | 5.05B | 4.43B |
| Net Cash (Debt) | -5.72B | -5.35B | -5.05B | -4.48B | -4.43B | -5.20B | -4.81B | -3.83B | -2.78B | -2.95B | -4.52B | -3.70B |
| Shares Outstanding | 80.90M | 82.30M | 82.20M | 83.00M | 82.90M | 83.80M | 83.40M | 83.70M | 83.80M | 84.30M | 83.90M | 84.90M |
This table shows 12 quarterly periods of Labcorp's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow LH's reporting calendar. What is a balance sheet?